Practical Guidelines Management of Graves Ophthalmopathy

Imam Subekti; Pradana Soewondo; Suharko Soebardi; Budiman Darmowidjojo; Dante Saksono Harbuwono; Dyah Purnamasari; Tri Juli Edi Tarigan; Wismandari Wisnu; Dicky Levenus Tahapary; Farid Kurniawan; M Sidik; Syntia Nusanti; Salmarezka Dewiputri; Hernawita Suharko; Gusti G Suardana; Indrati Suroyo; Vally Wulani; Alvita Dewi Siswoyo; Soehartati Gondhowiardjo; Henry Kodrat

Practical Guidelines Management of Graves Ophthalmopathy

Acta Med Indones. 2019 Oct;51(4):364-371.

Affiliation

¹ Division of Endocrinology and Metabolism, Department of Internal Medicine, Cipto Mangunkusumo General Hospital, Faculty of Medicine Universitas Indonesia, Jakarta. imam.subekti@ui.ac.id.

PMID: 32041923

Abstract

Graves' ophthalmopathy is the most common extra-thyroid manifestation in patients with Graves' disease, based on inflammatory and autoimmune conditions in orbital tissue. This practical guideline was formed by a multidiciplinary team, and is intended to provide guidance for diagnosis and management of Graves' ophthalmopathy in daily clinical practice to improve quality of care and treatment outcome.

Keywords: Graves’ ophthalmopathy; diagnosis; management.

Publication types

Practice Guideline

MeSH terms

Anti-Inflammatory Agents / therapeutic use
Combined Modality Therapy
Decompression, Surgical
Disease Management
Glucocorticoids / therapeutic use
Graves Ophthalmopathy / diagnosis*
Graves Ophthalmopathy / drug therapy
Graves Ophthalmopathy / radiotherapy
Graves Ophthalmopathy / therapy*
Humans
Immunosuppressive Agents / therapeutic use
Phosphodiesterase Inhibitors / therapeutic use
Radiotherapy Dosage
Radiotherapy, Conformal / methods
Risk Assessment

Substances

Anti-Inflammatory Agents
Glucocorticoids
Immunosuppressive Agents
Phosphodiesterase Inhibitors